Reprogramming of the Antibacterial Drug Vancomycin Results in Potent Antiviral Agents Devoid of Antibacterial Activity
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Reprogramming of the Antibacterial Drug Vancomycin Results in Potent Antiviral Agents Devoid of Antibacterial Activity
Authors
Keywords
-
Journal
Pharmaceuticals
Volume 13, Issue 7, Pages 139
Publisher
MDPI AG
Online
2020-06-29
DOI
10.3390/ph13070139
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Influenza virus entry via the GM3 ganglioside-mediated platelet-derived growth factor receptor β signalling pathway
- (2019) Pieter Vrijens et al. JOURNAL OF GENERAL VIROLOGY
- Synthesis and anti‐coronavirus activity of a series of 1‐thia‐4‐azaspiro[4.5]decan‐3‐one derivatives
- (2019) Çağla Begüm Apaydın et al. ARCHIV DER PHARMAZIE
- Superior inhibition of influenza virus hemagglutinin-mediated fusion by indole-substituted spirothiazolidinones
- (2019) Gökçe Cihan-Üstündağ et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Advancements in Host-Based Interventions for Influenza Treatment
- (2018) Tsz-Fung Yip et al. Frontiers in Immunology
- Structure-activity relationship studies of lipophilic teicoplanin pseudoaglycon derivatives as new anti-influenza virus agents
- (2018) Zsolt Szűcs et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- In vitro characterization of baloxavir acid, a first-in-class cap-dependent endonuclease inhibitor of the influenza virus polymerase PA subunit
- (2018) Takeshi Noshi et al. ANTIVIRAL RESEARCH
- Risk factors for serious outcomes associated with influenza illness in high- versus low- and middle-income countries: Systematic literature review and meta-analysis
- (2017) Brenda L. Coleman et al. Influenza and Other Respiratory Viruses
- Teicoplanin inhibits Ebola pseudovirus infection in cell culture
- (2016) Yizhuo Wang et al. ANTIVIRAL RESEARCH
- Antiviral therapies on the horizon for influenza
- (2016) Lieve Naesens et al. CURRENT OPINION IN PHARMACOLOGY
- Fighting viruses with antibiotics: an overlooked path
- (2016) Philippe Colson et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Synthesis and biological evaluation of lipophilic teicoplanin pseudoaglycon derivatives containing a substituted triazole function
- (2016) Zsolt Szűcs et al. JOURNAL OF ANTIBIOTICS
- Glycopeptide Antibiotics Potently Inhibit Cathepsin L in the Late Endosome/Lysosome and Block the Entry of Ebola Virus, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
- (2016) Nan Zhou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A few atoms make the difference: Synthetic, CD, NMR and computational studies on antiviral and antibacterial activities of glycopeptide antibiotic aglycon derivatives
- (2015) Ilona Bereczki et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Adamantane-Resistant Influenza A Viruses in the World (1902–2013): Frequency and Distribution of M2 Gene Mutations
- (2015) Guoying Dong et al. PLoS One
- Semisynthetic teicoplanin derivatives as new influenza virus binding inhibitors: Synthesis and antiviral studies
- (2014) Ilona Bereczki et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Influenza virus resistance to neuraminidase inhibitors
- (2013) Mélanie Samson et al. ANTIVIRAL RESEARCH
- Mutational Analysis of the Binding Pockets of the Diketo Acid Inhibitor L-742,001 in the Influenza Virus PA Endonuclease
- (2013) A. Stevaert et al. JOURNAL OF VIROLOGY
- Emerging Antiviral Strategies to Interfere with Influenza Virus Entry
- (2013) Evelien Vanderlinden et al. MEDICINAL RESEARCH REVIEWS
- Synthesis of isoindole and benzoisoindole derivatives of teicoplanin pseudoaglycon with remarkable antibacterial and antiviral activities
- (2012) Attila Sipos et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Synthesis of fluorescent ristocetin aglycon derivatives with remarkable antibacterial and antiviral activities
- (2012) Attila Sipos et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistance
- (2012) Jennifer L. McKimm-Breschkin Influenza and Other Respiratory Viruses
- Intracytoplasmic Trapping of Influenza Virus by a Lipophilic Derivative of Aglycoristocetin
- (2012) E. Vanderlinden et al. JOURNAL OF VIROLOGY
- An Analogue of the Antibiotic Teicoplanin Prevents Flavivirus Entry In Vitro
- (2012) Tine De Burghgraeve et al. PLoS One
- Click Chemistry: 1,2,3-Triazoles as Pharmacophores
- (2011) Sandip G. Agalave et al. Chemistry-An Asian Journal
- Inhibition of hepatitis C virus replication by semi-synthetic derivatives of glycopeptide antibiotics
- (2011) S. Obeid et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections
- (2009) Yousuke Furuta et al. ANTIVIRAL RESEARCH
- Anti-influenza virus activity and structure–activity relationship of aglycoristocetin derivatives with cyclobutenedione carrying hydrophobic chains
- (2009) Lieve Naesens et al. ANTIVIRAL RESEARCH
- Synthesis and Evaluation of Vancomycin Aglycon Analogues That Bear Modifications in the N-Terminald-Leucyl Amino Acid
- (2009) Christine M. Crane et al. JOURNAL OF MEDICINAL CHEMISTRY
- Diazo Transfer−Click Reaction Route to New, Lipophilic Teicoplanin and Ristocetin Aglycon Derivatives with High Antibacterial and Anti-influenza Virus Activity: An Aggregation and Receptor Binding Study
- (2009) Gábor Pintér et al. JOURNAL OF MEDICINAL CHEMISTRY
- Global Transmission of Oseltamivir-Resistant Influenza
- (2009) Anne Moscona NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More